Don’t miss a thing! Sign up to get the latest announcements, important dates, and news.

News & Updates

Vascular Leaders Forum Convenes to Tackle Challenges in Carotid Artery Disease

April 16, 2018

VIVA Physicians presented the second Vascular Leaders Forum (VLF) April 6 in Washington, D.C., bringing together stakeholders in patient care to explore the complexities of treating patients with carotid artery disease and ways to increase access to care. The first VLF was held in 2016 and was a natural extension of VI ...

News & Updates

​ VIVA Physicians and the American Heart Association fund new 2-year grant and career development program

March 19, 2018

DALLAS and SAN JOSE, Calif, March 13, 2018 — The American Heart Association and VIVA Physicians, Inc. announced today a two-year $1 million grant program to support research initiatives in vascular disease and career development opportunities for early career investigators at the post-doctoral level. The research suppo ...

News & Updates

VIVA Continues Its Focus on Multidisciplinary Education

December 1, 2017

As the field of vascular medicine rapidly evolves, VIVA (Vascular InterVentional Advances) continues to be at the forefront of interactive, multispecialty education. Now in its 16th year, this annual conference offers attendees the opportunity to hear distinguished speakers in the vascular medicine field discuss the mo ...

News & Updates

Efficacy of Philips' Stellarex .035" low-dose drug-coated balloon demonstrated in clinical trial at two years

September 14, 2017

- Two-year data from the ILLUMENATE European randomized clinical trial (EU RCT) validates durable clinical performance of Stellarex low-dose drug-coated balloon - Trial includes 328 peripheral arterial disease patients from 18 centers across Germany and AustriaAMSTERDAM and LAS VEGAS, Sept. 14, 2017 /PRNewswire/ -- Roy ...

News & Updates

Final Five Unpublished Vascular Clinical Trial Results Announced at VIVA 17

September 13, 2017

LAS VEGAS, Sept. 13, 2017 /PRNewswire-USNewswire/ -- VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the final five of 20 highly anticipated late-breaking clinical trial results at VIVA 17 hosted at the Wynn ...

News & Updates

New Unpublished Vascular Clinical Trial Results Announced At VIVA 17

September 13, 2017

LAS VEGAS, Sept. 13, 2017 /PRNewswire-USNewswire/ -- VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the second five of twenty highly anticipated late-breaking clinical trial results at VIVA 17 hosted at the ...

News & Updates

First Round Of Late-Breaking Endovascular Clinical Trial Results Announced At VIVA 17

September 12, 2017

LAS VEGAS, Sept. 12, 2017 /PRNewswire-USNewswire/ -- VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announced the first five of 20 highly anticipated late-breaking clinical trial results on Tuesday morning at VIVA 17, ...

News & Updates

Groundbreaking Endovascular Clinical Trial Results Announced At VIVA 17

September 12, 2017

LAS VEGAS, Sept. 12, 2017 /PRNewswire-USNewswire/ -- VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the second five of twenty 20 highly anticipated late-breaking clinical trial results at VIVA 17 hosted at t ...

News & Updates

Philips showcases integrated vascular solutions at VIVA 2017 to advance image-guided therapy procedures

September 11, 2017

- Highlights patient-centric interventional peripheral vascular solutions for diagnosis, image-guided therapy and connected care- Data to be presented from the ILLUMENATE European randomized clinical trial (EU RCT) evaluating Philips Spectranetics' Stellarex™ drug-coated balloon AMSTERDAM and LAS VEGAS, Sept. 11, 2017 ...

News & Updates

Results From 20 Highly Anticipated Vascular Interventional Clinical Trials To Be Presented At VIVA 17

August 1, 2017

LAS VEGAS, Aug. 1, 2017 /PRNewswire-USNewswire/ -- (Sept. 12–13, 2017) — Results from 20 clinical trials featuring the most recent research, procedures and devices in vascular Interventional technology and treatment will be released on Tuesday and Wednesday, Sept. 12 and 13 at the annual VIVA Conference. The conference ...

News & Updates

Ultrasound-Guided Vascular Access

April 21, 2017

Vascular access complications are amongst the most common problems that negatively impact the outcomes of endovascular procedures.  Despite this fact, adequate attention to the technique of gaining safe access has been lacking.  Many interventionalists still rely on the dated standard of fluoroscopically “flashing” a h ...

News & Updates

There is a Lot More to Know About Managing Pulmonary Emboli

May 18, 2016

Michael R. Jaff, DO, and Kenneth Rosenfield, MD Vascular Medicine, Massachusetts General Hospital, Boston We know a lot about pulmonary emboli (PE). We know that that, though the risk for PE increases with each decade over the age of 40 (1), there is no adult patient population that is immune to the potentially devasta ...

News & Updates

The Best Evidence for EndoVascular Therapy First for Patients with Critical Limb Ischemia

January 21, 2016

Critical Limb Ischemia (CLI) represents a complex pathologic state characterized by extensive and long-segment arterial occlusive disease, multiple vessel involvement, frequent calcifications, and microcirculatory disturbance affecting the pedal loop and cutaneous perfusion. Toe gangrene in a patient presenting with cr ...

News & Updates

Is Warfarin Still Relevant?

February 26, 2015

With the emergence of the novel oral anticoagulants (NOAC) as alternatives for warfarin has come the potential of transforming modern clinical practice for venous thromboembolism (VTE). Dabigitran, Rivaroxaban, Apixaban and Edoxaban, unlike warfarin, do not require monitoring eliminating many of the frustrations associ ...

News & Updates

Edoxaban in venous thromboembolism: Clinical considerations

January 10, 2015

Edoxaban (Marketed as Savaysa, Daiichi Sankyo, Tokyo), an oral, once-daily factor Xa inhibitor, was approved by the FDA on January 8, 2015 for the prevention of stroke and systemic embolism in non-valvular atrial fibrillation and for the treatment of venous thromboembolism (VTE). In a press release issued by the FDA, t ...

News & Updates

Sole Pedal Access as primary approach in invasive management of PAD

December 29, 2014

Peripheral arterial disease is a prevalent disease affecting 8 million Americans and is associated with significant morbidity like intermittent claudication, critical limb ischemia and limb loss. Interventions for peripheral arterial disease have recently moved towards more endovascular procedures compared to tradition ...

News & Updates

What is the best treatment for this acute limb ischemia patient?

December 18, 2014

This issue is complex but approached in a systematic way most patients declare themselves better suited to one form of revascularisation therapy over another (the options being Chemical Versus Mechanical Lysis Versus Surgical Thrombectomy). The decision making and treatment algorithm starts with a thorough history and ...

News & Updates

What Happens to Patients Who Suffer Pulmonary Embolus

December 5, 2014

Pulmonary embolism (PE) is a common and often fatal disease process whose clinical presentation and long term outcome is widely variable. The natural evolution of PE ranges significantly, with abrupt hemodynamic compromise and death within one hour for approximately 10% of all cases. In contrast, approximately one thir ...

News & Updates

Fenestrated and Branched Stent Grafts are Best for Arch Aneurysms

November 26, 2014

Aortic arch aneurysms present a significant clinical challenge. Despite improvements in operative techniques and peri-operative care, open repair of aortic arch aneurysms is still plagued by significant morbidity and mortality. Endovascular approaches have significantly altered our approach to aortic arch disease, with ...

News & Updates

Pulmonary Embolism Response Team

November 18, 2014

The problem: There is much uncertainty in the management of pulmonary embolism Acute pulmonary embolism (PE) presents diagnostic and management challenges to the contemporary vascular medicine specialist: PE remains a great masquerader given its protean, non-specific manifestations, and, in terms of management, guidel ...

News & Updates

Approach to Patients with Acute Limb Ischemia

November 16, 2014

The assessment and management of acute limb ischemia begins with a thorough history and physical exam. The most important aspects include timing of symptom onset and the “5 Ps” (pain, pallor, pulselessness, paresthesias, and paralysis). Once the diagnosis has been suspected, Doppler ultrasound should be performed, an ...

News & Updates

Common Femoral Artery: Mine? Yours? Oops!

November 11, 2014

Over the course of the past two decades, advances in endovascular interventions have dramatically changed the way we treat vascular disease. Targets that once were sacred to the gold standard of open surgery have been converted to a minimally invasive approach, where the impact on the patient is lessened and the quali ...

News & Updates

Tibial and Pedal Runoff Salvage: Indications and Techniques

November 6, 2014

How Aggressive Should I Be in Salvaging Tibial and Pedal Runoff and What Are the Techniques? The current approach to limb salvage is a moving target. Endovascular therapy is accepted as first line in the majority of cases yet the definitive answer to the most appropriate approach is 5 years away (BEST trial). Till the ...

News & Updates

What Did CORAL Tell Us, and What Didn’t CORAL Tell Us?

November 6, 2014

The consideration to intervene on patients with atherosclerotic renal artery stenosis (ARAS) has been controversial ever since Blum’s publication of 74 ostial ARAS cases . There have been a number of single center and multicenter registries designed to demonstrate the safety and efficacy of renal artery stent deploy ...

News & Updates

Drug-Eluting Balloons Are All You Need!

October 25, 2014

Despite being more effective than balloon angioplasty for preventing restenosis, the benefit of nitinol stenting in infrainguinal vessels is only fair with 1-year restenosis-rates being still in the range 20 to 50% depending on and increasing with lesion length or even higher in diabetic patients. Just recently publish ...

News & Updates

Endovascular Stroke Treatment: New Challenges, New Opportunities

October 25, 2014

Current acute ischemic stroke therapy has been guided by the recanalization hypothesis, the concept that we must restore flow to ischemic but viable tissue by reopening the occluded vessel. Recanalization preserves threatened neural tissue improving patient outcome. While recanalization may be spontaneous, this can be ...

News & Updates

Atherectomy for Peripheral Artery Disease

October 7, 2014

Endovascular atherectomy has been used for treatment of peripheral artery disease for more than two decades. In that time, there has been a steady rollout of devices, each equipped with a sexy new moniker. Atherectomy: Exploring the Evidence Despite much investment and marketing by a handful of manufacturers, atherecto ...

News & Updates

What’s in My Bag: A sit-down with Dr. Michael Bacharach

October 6, 2014

What’s in My Bag: A candid discussion with some of the nation’s greatest peripheral interventionalists—including equipment preferences, technical tips, and insights into the future of peripheral intervention. This week in “What’s in My Bag”: A sit-down with Dr. Michael Bacharach BIO Medical School: University ...

News & Updates

Thrombolysis for Deep Vein Thrombosis

October 6, 2014

In the absence of arterial compromise, the treatment of symptomatic deep vein thrombosis (DVT) has long plagued clinicians. The mainstay of chronic therapy— anticoagulation—prevents clot propagation and recurrent thrombosis but offers little acute relief to patients with painful DVT and has low success rates in foresta ...

News & Updates

Screening ABIs in Asymptomatic Adults

October 6, 2014

Guideline Recommendations In 2013, the US Preventive Services Task Force (USPTF) updated its 2005 guidelines to state that there was insufficient evidence to support screening ankle-brachial index measurement (ABI) in asymptomatic adults, regardless of age or risk factors  (grade I statement). (1) This recommendation c ...

News & Updates

Introduction to Peripheral Artery Disease

October 6, 2014

Peripheral Artery Disease or PAD is defined by the presence of a stenosis or occlusion in the aorta or branch vessels which supply the lower extremities. PAD is most commonly caused by atherosclerosis. The three cardinal manifestations of atherosclerosis are coronary artery disease, cerebrovascular disease  and PAD. On ...

News & Updates

Thrombolysis for Pulmonary Embolism – Study Review

October 6, 2014

What was the study Question? Does thrombolytic therapy in pulmonary embolism (PE), especially in those with hemodynamic stability and evidence of right ventricular (RV) dysfunction, really increase the rates of intracranial hemorrhage (ICH) without affecting mortality? Why was the study needed? A recent randomized cont ...

News & Updates

Statins in Critical Limb Ischemia – Study Review

October 6, 2014

Association Between Statin Medications and Mortality, Major Adverse Cardiovascular Event, and Amputation-Free Survival in Patients with Critical Limb Ischemia. Westin G, Armstrong E, Bang H, et al JACC February 25h 2014 What was the study question? This study sought to determine whether the use of statin medications wa ...

News & Updates

Endovascular therapy for retroperitoneal hemorrhage

October 6, 2014

Retroperitoneal hemorrhage (RPH), the most feared complication of transfemoral access for endovascular procedures, occurs in 0.1-0.7% of cases and is associated with a 10% mortality rate. Traditionally, a surgical consult and expectant management with transfusion (required in 70-80% of cases) were the mainstays of trea ...

News & Updates

Emerging Therapies for Pulmonary Embolism

October 6, 2014

Anticoagulation is the first-line therapy for all forms of pulmonary embolism. Systemic thrombolysis is also effective for those pulmonary embolism patients with shock, but it comes at a cost of increased bleeding ( http://www.ncbi.nlm.nih.gov/pubmed/15262836). There is less certainty regarding the optimal treatment fo ...

News & Updates

Paget-Schrotter Syndrome or Effort Thrombosis: What is the most current treatment?

October 6, 2014

Clinical Vignette: A 41-year-old female presented to hospital with a swollen, painful right upper extremity, which had been progressive over several days. The patient was an avid athlete who performed vigorous upper body exercised on a regular basis. Initial work up including upper extremity ultrasound confirmed right ...

News & Updates

Angiosomes in Critical Limb Ischemia

October 6, 2014

Critical limb ischemia is ischemic rest pain and / or nonhealing wounds of the lower extremity due to reduced arterial perfusion (1). Patients with critical limb ischemia are at elevated risk for amputation (2). Revascularization is an accepted treatment for patients with critical limb ischemia, when the goal is limb s ...

News & Updates

Just a DASH of VTE

October 5, 2014

DASH prediction model for reoccurrence risk in 1st time unprovoked VTE Assessing the risk of recurrent VTE after a treatment period or determining when to stop therapy is a common concern amongst practitioners.  The optimal goal of weighing ones bleeding risk versus their risk of VTE recurrence was the objective of a m ...

News & Updates

Directional atherectomy for infra-inguinal atherosclerosis

October 4, 2014

What is directional atherectomy (DA)? DA is a percutaneous technique that includes a directional cutter positioned to address the area of greatest plaque burden within a vessel and maximize luminal gain both above and below the knee. It is performed using the TurboHawk or SilverHawk devices manufactured by covedian. Mo ...

News & Updates

Critical Limb Ischemia Outcomes

October 1, 2014

There is a need for more clinical trial data to facilitate medical decision making when caring for patients with critical limb ischemia (CLI). Traditionally, outcome assessment in clinical trials for this patient population has focused on amputation-free survival and patency. Choosing the optimal outcome that is import ...